Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00400062 · ClinicalTrials.gov registry record
MIND-ICU Study: Delirium and Dementia in Veterans Surviving ICU Care
A clinical trial of Aging and Dementia, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 800
- Enrollment target
- 3
- Study locations
NCT00400062: Completed study of Aging and Dementia, sponsored by VA Office of Research and Development.
NCT00400062 is a study of Aging and Dementia that has completed, run by VA Office of Research and Development. The registered enrollment target is 800 participants, below the 2,192-participant average among 262 other Aging trials with a reported enrollment target (64% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00400062, a study of Aging and Dementia, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 800 participants
- Enrollment target
- 3
- Study locations
Study Summary
This will be the first large cohort study to define the epidemiology of and identify modifiable risk factors for long-term CI and functional deficits of ICU survivors. The investigators will measure the independent contribution of risk factors such as delirium and exposure to sedative and analgesic medications to the incidence of long-term CI, controlling for established risk factors (e.g., age, pre-existing CI, and apoE genotype). Defining the contributions of these risk factors will make it possible to develop preventive and/or treatment strategies to reduce the incidence, severity and/or duration of long-term CI and improve functional recovery of patients with acute critical illness.
Study Locations (3)
Tennessee
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN - Nashville
Utah
- VA Salt Lake City Health Care System, Salt Lake City, UT - Salt Lake City
Washington
- VA Puget Sound Health Care System Seattle Division, Seattle, WA - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2007-07-01 |
| Est. Completion | 2017-12-01 |
What the finished NCT00400062 record still lists
NCT00400062 is an observational study that tracks outcomes without assigning an intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, below the 2,192-participant average among 262 other Aging trials with a reported enrollment target (64% lower).
The record links to 3 conditions, with Aging appearing as the primary indexed condition, and to 0 interventions.
NCT00400062 reports a single indexed study location in Tennessee, Utah, Washington.
Frequently Asked Questions
What is clinical trial NCT00400062 about?
NCT00400062 is a clinical study titled "MIND-ICU Study: Delirium and Dementia in Veterans Surviving ICU Care". This will be the first large cohort study to define the epidemiology of and identify modifiable risk factors for long-term CI and functional deficits of ICU survivors. The investigators will measure the independent contribution of risk factors such as delirium and exposure to sedative and analgesic ...
What is the current status of trial NCT00400062?
This trial is currently completed. The enrollment target is 800 participants. The study started on 2007-07-01. Estimated completion is 2017-12-01.
What conditions does trial NCT00400062 study?
This clinical trial studies the following conditions: Aging, Dementia, Delirium.
Who is sponsoring clinical trial NCT00400062?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00400062 being conducted?
This trial has 3 study locations across Tennessee, Utah, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00400062's enrollment target sits among peer trials
800 16th of 262 higher than 247 of 262 other Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses
RECRUITING · Phase 4
-
Effect of a Daily Supplement on Plasma PAI-1 Levels
RECRUITING · Phase 1
-
Using Nicotine to Reverse Age-related Auditory Processing Deficits
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI